Toxicology review and risk assessment of resorcinol: Thyroid effects

Regulatory Toxicology and Pharmacology

Volumn 36, Issue 2, 2002, Pages 198-210

  Lynch, Barry S ^a   Delzell, Elizabeth S ^b   Bechtel, David H ^c  

^a Cantox Health Sciences International   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Cantox US   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; RESORCINOL; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CONTAMINATION; BIOASSAY; CONTROLLED STUDY; DOSE RESPONSE; GOITER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; RODENT; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE SYNTHESIS; WATER CONTAMINATION; WATER SUPPLY;

BACTERIA (MICROORGANISMS); RODENTIA;

EID: 0036979091     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.2002.1585     Document Type: Article

References (100)

1. Alison, R. H., Capen, C. C., and Prentice, D. E. (1994). Neoplastic lesions of questionable significance to humans. Toxicol. Pathol. 22, 179-186.
2. American Conference of Governmental Industrial Hygienists (ACGIH) (1992). Resorcinol. In Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th ed., Vol. 3, pp. 1333-1336. ACGIH, Cincinnati, OH.
3. Ames, B. N., Magaw, R., and Gold, L. S. (1987). Ranking possible carcinogenic hazards. Science 236, 71-280.
4. Anderson, D. (1993). Genetic toxicology. In Experimental Toxicology: The Basic Issues (D. Anderson and D. M. Conning, Eds.), 2nd ed., pp. 243-312. Roy. Soc. of Chem., Cambridge.
5. 131I) by the thyroid of the rat. Biochem. J. 50, 473-479.
6. Ashby, J. (1996). Alternatives to the 2-species bioassay for the identification of potential human carcinogens. Hum. Exp. Toxicol. 15, 183-202.
7. Berthezene, F., Fournier, M., Bernier, E., and Mornex, R. (1973). L' hypothyroidie induite par la resorcine. a propos de deux observations [Resorcin Induced Hypothyroidism: Report of 2 Cases]. Lyon Med. 230, 319-323.
8. Berthezene, F., Perrot, L., Munari, Y., and Ponsin, G. (1979). Effets multiples du resorcinol sur la fonctionthyroidienne [Multiple Effects of Resorcinol on Thyroid Function]. Ann. Endocrinol. (Paris). 40, 67-68.
9. Boutwell, R. K., and Bosch, D. K. (1959). The tumor-promoting action of phenol and related compounds for mouse skin. Cancer Res. 19, 413-427.
10. Bracher, M., Swistak, J., and Noser, F. (1981). Studies on the potential in vivo induction of sister-chromatid exchanges in rat bone marrow by resorcinol. Mutat. Res. 91, 363-369.
11. Bray, H. G., Humphris, B. G., Thorpe, W. V., White, K., and Wood, P. B. (1952). Kinetic studies of the metabolism of foreign organic compounds. 4. The conjugation of phenols with sulfuric acid. Biochem. J. 52, 419-423.
12. Brucker-Davis, F. (1998). Effects of environmental synthetic chemicals on thyroid function. Thyroid 8, 827-856.
13. Brusick, D. (1994). Genetic toxicology. In: Hayes, A. W. (Ed.). Principles and Methods of Toxicology (3rd ed.) (A. W. Hayes, Ed.), pp. 545-577. Raven Press, Ltd., New York.
14. Bull, G. M., and Fraser, R. (1950). Myxoedema from resorcinol ointment applied to leg ulcers. Lancet, May 6, 851-855.
15. Burnett, C., Lanman, B., Giovacchini, R., Wolcott, G., Scala, R., and Keplinger, M. (1975). Long-term toxicity studies on oxidation hair dyes. Food Cosmet. Toxicol. 13, 353-357.
16. Burnett, D., Goldenthal, E. I., Harris, S. B., Wazeter, F. X., Strausburg, J., Kapp, R., and Voelker, R. (1976). Teratology and percutaneous toxicity studies on hair dyes. J. Toxicol. Environ. Health. 1, 1027-1040.
17. Canaris, G. J., Manowitz, N. R., Mayor, G., and Ridgway, E. C. (2000). The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526-534.
18. Capen, C. C., Roland, R. A., and Yarrington, J. T. (1991). Endocrine system. In Handbook of Toxicologic Pathology (W. M. Haschek and C. G. Rousseaux, Eds.), pp. 675-760. Academic Press, New York/Toronto.
19. Cheymol, J., Gay, Y., and Laveden, J. P. (1951). Y A-tile une action antitthyroïdiene des diphénols? C. R. Seanc. Soc. Biol. Fil. 145, 999-1001.
20. Cooksey, R. C., Gaitan, E., Lindsay, R. H., Hill, J. B., and Kelly, K. (1985). Humic substances, a possible source of environmental goitrogens. Org. Geochem. 8, 77-80.
21. Cosmetic Ingredient Review (CIR) (1986). Final report on the safety assessment of 2-methylresorcinol and resorcinol. J. Am. Coll. Toxicol. 5, 167-203.
22. Curran, P. G., and Degroot, L. J. (1991). The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr. Rev. 12, 135-150.
23. Darroudi, F., and Natarajan, A. T. (1983). Cytogenetic analysis of human peripheral blood lymphocytes (in vitro) treated with recorcinol. Mutat. Res. 124, 179-189.
24. Deichmann, W., and Thomas, G. (1943). Glucuronic acid in the urine as a measure of the absorption of certain organic compounds. J. Ind. Hyg. Toxicol. 25, 286-292.
25. DiNardo, J. C., Picciano, J. C., Schnetzinger, R. W., Morris, W. E., and Wolf, B. A. (1985). Teratological assessment of five oxidative hair dyes in the rat. Toxicol. Appl. Pharmacol. 78, 163-166.
26. Divi, R. L., and Doerge, D. R. (1994). Mechanism-based inactivation of lactoperoxidase and thyroid peroxidase by resorcinol derivatives. Biochemistry 33, 9668-9674.
27. Dohler, K. D., Wong, C. C., and Von Zur Muhler, A. (1979). The rat as a model for the study of drug effects on thyroid function: Consideration of methodological problems. Pharmacol. Ther. 5, 305-318.
28. 131 in rats. Lancet, May 6, 855-856.
29. Doniach, I., and Logothetopoulos, J. (1953). The goitrogenic action of resorcinol in rats. Br. J. Exp. Pathol. 34, 146-151.
30. Flickinger, C. W. (1976). The benzenediols: Catechol, resorcinol and hydroquinone - A review of the industrial toxicology and current industrial exposure limits. Am. Ind. Hyg. Assoc. J. 37, 596-606.
31. Gaitan, E. (1973). Water-borne goitrogens and their role in the etiology of endemic goiter. World Rev. Nutr. Diet. 17, 53-90.
32. Gaitan, E. (1980). Goitrogens in the etiology of endemic goiter. In Endemic Goiter and Endemic Cretinism (J. B. Stanbury and B. Hetzel, Eds.), pp. 219-236. Wiley, New York.
33. Gaitan, E. (1983). Endemic goiter in Western Columbia. Ecol. Dis. 2, 295-308.
34. Gaitan E. (1986). Iodine-sufficient goiter and autoimmune thyrioditis: The Kentucky and Colombian experience. In Frontiers in Thyroidology (G. Medeiros-Neto and E. Gaitan, Eds.), Vol. 1, pp. 19-25. Plenum, New York.
35. Gaitan, E. (1990). Goitrogens in food and water. Annu. Rev. Nutr. 10, 21-39.
36. Gaitan, E., Wahner, H. W., Correa, P., Bernal, R., Jubiz, W., Gaitan, J. E., and Llanos, G. (1968). Endemic goiter in the Cauca Valley. I. Results and limitations of twelve years of iodine prophylaxis. J. Clin. Endocrinol. Metab. 28, 1730-1740.
37. Gaitan, E., Wahner, H. W., Cuello, C., Correa, P., Jubiz, W., and Gaitan, J. E. (1969). Endemic goiter in the Cauca Valley. II. Studies of thyroid pathophysiology. J. Clin. Endocrinol. Metab. 29, 675-683.
38. Gaitan, E., Merino, H., Rodriguez, G., Medina, P., Meyer, J. D., DeRouen, T. A., and MacLennan, R. (1978). Epidemiology of endemic goitre in western Colombia. Bull. WHO 56, 403-446.
39. Gaitan, E., Medina, P., DeRouen, T. A., and Sun-Zia, M. (1980). Goiter prevalence and bacterial contamination of water supplies. J. Clin. Endocrinol. Metab. 51, 957-961.
40. Gaitan, E., Lindsay, R. H., Jolley, R. L., Cooksey, R. C., Legan, J., and Hill, J. (1986). Antithyroid and goitrogenic activities of organic pollutants in water supplies from iodine-sufficient areas with endemic thyroid disorders. In 191st National Meeting of the American Chemical Society, Division of Environmental Chemistry, New York, NY, April 13-18, 1986, Vol. 26, pp. 68-71.
41. Gaitan, E., Jolley, R. L., Lindsay, R. H., Cooksey, R. C., Hill, J. B., and Island, D. P. (1987/1988). Resorcinol: Final goitrogenic product in water from a goitrogenic well. Clin. Ecol. 4, 176-184.
42. Gaitan, E., Cooksey, R. C., Meydrech, E. F., Legan, J., Gaitan, G. S., Astudillo, J., Guzman, R., Guzman, N., and Medina, P. (1989). Thyroid function in neonates from goitrous and nongoitrous iodine-sufficient areas. J. Clin. Endocrinol. Metab. 69, 359-363.
43. Gans, E. H. (1980). Unpublished. Letter to Dr. Wallace Guess, Chairman of the Antimicrobial II, O-T-C Products Review Panel. Attachment: Draft report containing additional data.
44. Garton, G. A., and Williams, R. T. (1949). Studies in detoxication. 21. The fates of quinol and resorcinol in the rabbit in relation to the metabolism of benzene. Biochem. J. 44, 234-238.
45. Giles, A. L., Chung, C. W., and Kommineni, C. (1976). Dermal carcinogenicity study by mouse-skin painting with 2,4-toluenediamine alone or in a representative hair dye formulations. J. Toxicol. Environ. Health. 1, 433-440.
46. Gocke, E., King, M.-T., Eckhardt, K., and Wild, D. (1981). Mutagenicity of cosmetics ingredients licensed by the European communities. Mutat. Res. 90, 91-109.
47. Guinet, P., Tourniaire, J., Peyrin, J. O., et al. (1967). Clinical and biological study of a goiter due to resorcinol abstract hypo thyroid. Semin. Hop. Paris 43, 145.
48. Hart, F. D., and Maclagan, N. F. (1951). Myxoedema from resorcinol ointment. Lancet, Mar. 3, 530-531.
49. Hirose, M., Yamaguchi, S., Fukushima, S., Hasegawa, R., Takahashi, S., and Ito, N. (1989). Promotion by dihydroxybenzene derivatives of N-methyl-N′-nitro-N-nitrosoguamidine-induced F344 rat forestomach and glandular stomach carcinogenesis. Cancer Res. 49, 5143-5147.
50. Hobson, Q. J. G. (1951). Varicose ulceration of the legs and myxoedema and goitre following application of resorcinol ointment. Proc. R. Soc. Med. 44, 164.
51. Hossack, D. J. N., and Richardson, J. C. (1977). Examination of the potential mutagenicity of hair dye constituents using the micronucleus test. Experientia 33, 377-378.
52. International Agency for Research on Cancer (IARC) (1999). Resorcinol. In Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide (Parts 1-3), IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 7, pp. 1119-1131. IARC, Lyon.
53. Jansson, T., Curvall, M., Hedin, A., and Enzell, C. R. (1986). In vitro studies of biological effects of cigarette smoke condensate. II. Induction of sister-chromatid exchanges in human lymphocytes by weakly acidic, semivolatile constituents. Mutat. Res. 169, 129-139.
54. Katin, M. J., Teehan, B. P., Sigler, M. H., and Cilgore, G. S. (1977). Resorcinol-induced hypothyroidism in a patient on chronic hemodialysis. Ann. Intern. Med. 86, 447-449.
55. Kavlock, R. J. (1990). Structure-activity relationships in the developmental toxicity of substituted phenols: In vivo effects. Teratology 41, 43-59.
56. Kim, Y. C., and Matthews, H. B. (1987). Comparative metabolism and excretion of resorcinol in male and female F344 rats. Fundam. Appl. Toxicol. 9, 409-414.
57. Kinkel, H. J., and Holzmann, S. (1973). Study of long-term percutaneous toxicity and carcinogenicity of hair dyes (oxidizing dyes) in rats. Food Cosmet. Toxicol. 11, 641-648.
58. Klein, F., Ottis, V., and Velvart, J. (1950). Myxoedema from resorcinol ointment applied to leg ulcers. Lancet, Dec. 9, 768.
59. Kurata, Y., Fukushima, S., Hasegawa, R., Hirose, M., Shibata, M., Shirai, T., and Ito, N. (1990). Structure-activity relations in promotion of rat urinary bladder carcinogenesis by phenolic antioxidants. Jpn. J. Cancer Res. 81, 754-759.
60. Lindsay, R. H., and Gaitan, E. (1989). Polyhydroxyphenols and phenol derivatives. In Environmental Goitrogenesis (E. Gaitan, Ed.), pp. 73-93. CRC Press, Boca Raton, FL.
61. Lindsay, R. H., Gaitan, E., Jolley, R. L., Cooksey, R. C., and Hill, J. (1986). Antithyroid activity of organic pollutants in wastewater effluents from coal conversion processes. In 191st National Meeting of the American Chemical Society, Division of Environmental Chemistry, New York, NY, April 13-18, 1986, Vol. 26, No. 1, pp. 64-67.
62. Lindsay, R. H., Hill, J. B., Gaitan, E., Cooksey, R. C., and Jolley, R. L. (1992). Antithyroid effects of coal-derived pollutants. J. Toxicol. Environ. Health 37, 467-481.
63. Lundell, E., and Nordman, R. (1973). A case of infantile poisoning by topical application of Castellani's solution. Ann. Clin. Res. 5, 404-406.
64. Maronpot, R. R., Mitsumori, K., Mann, P., Takaoka, M., Yamamoto, S., Usui, T., Okamiya, H., Nishikawa, S., and Nomura, T. (2000). Inter-laboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model. Toxicology 156, 149-159.
65. Marsh, F. (1951). Myxoedema from resorcinol ointment. Lancet, Apr. 14, 855.
66. Maruyama, H., Amanuma, T., Nakae, D., Tsutsumi, M., Kondo, S., Tsujiuchi, T., Denda, A., and Konishi, Y. (1991). Effects of catechol and its analogs on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl)amine in Syrian hamsters. Carcinogenesis 12, 1331-1334.
67. McClain, R. M. (1994). Mechanistic considerations in the regulation and classification of chemical carcinogens. In Nutritional Toxicology (F. N. Kotsonis, M. Mackey, and J. Hjelle, Eds.), pp. 273-304. Raven Press, New York.
68. McGregor, D. B., Riach, C. G., Brown, A., Edwards, I., Reynolds, D., West, K., and Willington, S. (1988a). Reactivity of catecholamines and related substances in the mouse lymphoma L5178Y cell assay for mutagens. Environ. Mol. Mutagen. 11, 523-544.
69. McGregor, D. B., Brown, A., Cattanach, P., Edwards, I., Mcbride, D., Riach, C., and Caspary, W. J. (1988b). Responses of the L5178Y TK+/TK- mouse lymphoma cell forward mutation assay. II. 18 coded chemicals. Environ. Mol. Mutagen. 11, 91-118.
70. McLaren, E. H., and Alexander, W. D. (1979). Goitrogens. Clin. Endocrinol. Metab. 8, 129-144.
71. Merker, P. C., Yeung, D., Doughty, D., and Nacht, S. (1982). Pharmacokinetics of resorcinol in the rat. Res. Commun. Chem. Pathol. Pharmacol. 38, 367-388.
72. Meyer, J. D., Gaitan, E., Merino, H., and DeRouen, T. (1978). Geologic implications in the distribution of endemic goiter in Colombia, South America. Int. J. Epidemiol. 7, 25-30.
73. Miyata, Y., Fukushima, S., Hirose, S., Masui, T., and Ito, N. (1985). Short-term screening of bladder carcinogenesis in n-butyl-n-(4-hydroxylbutyl)nitrosamine-initiated, unilaterally ureter-ligated rats. Jpn. J. Cancer Res. 76, 828-834.
74. National Toxicology Program (NTP) (1992). Toxicology and Carcino-genesis Studies of Resorcinol (CAS No. 108-46-3) in F344/N rats and B6C3F1 Mice (Gavage Studies), NTP Technical Report Series, No. 403. NTP, Research Triangle Park, NC.
75. Okazaki, S., Hoshiya, T., Takahashi, S., Futakuchi, M., Saito, K., and Hirose, M. (1993). Modification of hepato- and renal carcinogenesis by catechol and its isomers in rats pretreated with N-ethyl-N-hydroxyethylnitrosamine. Teratogen. Carcinogen. Mutagen. 13, 127-137.
76. Paschin, Y. V., Bakhitova, L. M., and Benthen, T. I. (1986). Increased antimutagenic activity of simple substituted phenols mixed with the hindered phenolic antioxidant dibunol. Food Chem. Toxicol. 24, 881-883.
77. Pitney, W. R., and Fraser, T. R. (1953). The mode of action of antithyroid drugs: Results with two in vitro tests. J. Endocrinol. 9, 224-231.
78. Roberts, F. P., Wright, A. L., and O'Hagan. (1990). Hypothyroidism in textile workers. J. Soc. Occup. Med. 40, 153-156.
79. Rosenberg, I. N. (1952). The antithyroid activity of some compounds that inhibit peroxidase. Science 116, 503-505.
80. Sakano, Y., Tsuyoshi, T., Kobayashi, Y., Andoh, H., and Masamoto, Y. (1985). The role of the oxygen free-radicals in the mutagenesis of divalent phenols. Mutat. Res. 147, 272-273.
81. Samuel, K. C. (1955). Experimental production of goiter in rats: With resorcinol and its derivatives. Lab. Invest. 4, 90-105.
82. Seffner, W., Schiller, F., Heinze, R., and Breng, R. (1995). Subchronic application of humic acids and associated compounds provokes histological changes of goitre in the rat. Exp. Toxicol. Pathol. 47, 63-70.
83. Shibata, M. A., Yamada, M., Hirose, M., Asakawa, E., Tatematsu, M., and Ito, N. (1990). Early proliferative responses of forestomach and glandular stomach of rats treated with five different phenolic antioxidants. Carcinogenesis 1, 425-429.
84. Spengler, J., Osterburg, I., and Korte, R. (1986). Teratogenic evaluation of p-toluenediamine sulfate resorcinol and p-aminophenol in rats and rabbits. (Abstract) Teratology. 33, 31 A.
85. Stenbäck, F. (1977). Local and systemic effects of commonly used cutaneous agents: Lifetime studies of 16 compounds in mice and rabbits. Acta Pharmacol. Toxicol. 41, 417-431.
86. Stenbäck, F., and Shubik, P. (1974). Lack of toxicity and carcinogenicity of some commonly used cutaneous agents. Toxicol. Appl. Pharmacol. 30, 7-13.
87. Stenius, U., Warholm, M., Rannug, A., Walles, S., Lundberg, I., and Höberg, J. (1989). The role of GSH depletion and toxicity in hydroquinone-induced development of enzyme-altered foci. Carcinogenesis 10, 595-599.
88. Stich, H. F., Rosin, M. P., Wu, C. H., and Powrie, W. D. (1981). The action of transition metals on the genotoxicity of simple phenols, phenolic acids and cinnamic acids. Cancer Lett. 14, 251-260.
89. Thomas, A. E., and Gisburn, M. A. (1961). Exogenous ochronosis and myxoedema from resorcinol. Br. J. Dermatol. 73, 378-381.
90. TOMA (1978). Occupational Health Evaluation of the Petrolia, Pennsylvania Plant of Koppers Company, Inc. Tabershaw Occupational Medicine Associates (TOMA). Final Report (Unpublished, undated).
91. TOMA (1980). Historical Prospective Mortality Study of Workers Employed at the Petrolia Plant of Koppers Company, Inc. Tabershaw Occupational Medicine Associates (TOMA). (Unpublished, March 5, 1980).
92. TOMA (1981). Occupational Health Evaluation of the Raleigh, North Carolina Plant of Koppers Co., Inc. Forest Products Group. Tabershaw Occupational Medicine Associates (TOMA). Final Report (Unpublished, October 2, 1981).
93. TOMA (1982). Occupational Health Evaluation of the Bridgeville, Pennsylvania Plant of Koppers Company, Inc. Organic Materials Group. Tabershaw Occupational Medicine Associates (TOMA). Final Report (Unpublished, July 16, 1982).
94. Tunbridge, W. M., Evered, D. C., Hall, R., Appleton, D., Brewis, M., Clark, F., Evans, J. G., Young, E., Bird, T., and Smith, P. A. (1977). The spectrum of thyroid disease in a community: The Whickham survey. Clin. Endocrinol. 7, 481-493.
95. Wahner, H. W., Mayberry, W. E., Gaitan, E., and Gaitan, J. E. (1971). Endemic goiter in the Cauca Valley. 3. Role of serum TSH in goitrogenesis. J. Clin. Endocrinol. Metab. 32, 491-496.
96. Walfish, P. G. (1983). Drug and environmentally induced neonatal hypothyroidism. In Congenital Hypothyroidism (J. H. Dussault and P. Walker, Eds.). Marcel Dekker, New York.
97. Wild, D., King, M.-T., Eckhardt, K., and Gocke, E. (1981). Mutagenic activity of aminophenols and diphenols, and relations with chemical structure. (Abstract). Mutat. Res. 85, 456.
98. Yamaguchi, S., Hirose, M., Fukushima, S., Hasegawa, R., and Ito, N. (1989). Modification by catechol and resorcinol of upper digestive tract carcinogenesis in rats treated with methyl-N-amylnitrosamine. Cancer Res. 49, 6015-6018.
99. Yamamoto, S., Urano, K., Koizumi, H., Wakana, S., Hioki, K., Mitsumori, K., Kurokawa, S., Hayashi, Y., and Nomura, T. (1998). Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ. Health Perspect. 106 (Suppl. 1), 57-69.
100. Yeung, D., Kantor, S., Nacht, S., and Gans, E. H. (1983). Percutaneous absorption, blood levels, and urinary excretion of resorcinol applied topically in humans. Int. J. Dermatol. 22, 321-324.